At the initial stages of the coronavirus pandemic, many countries developed pandemic preparedness plans to prepare health systems for the impending outbreak. As part of this process, projections were made on extra resources required to be deployed to the health system, following which national COVID-19 budgets were estimated. An important component of these projections were unit cost estimates of the clinical management of COVID-19. However, limited knowledge on the clinical care management and care pathway of COVID-19 in many countries posed challenges in estimating context-specific costs.
In this webinar, we discuss some of methods used at the start of the pandemic to estimate clinical management costs of COVID -19 and challenges faced in doing this, drawing on recent experience from South Africa and Kenya, presented by Dr Ijeoma Edoka, Research Director at PRICELESS and Dr Angela Kairu, research officer at the KEMRI-Wellcome Trust. Dr Maryam Huda will be chairing the event, and Dr Susmita Chatterjee will be discussing the papers and her experience in India.
While initial estimates have been useful for informing national COVID-19 budgets in many LMICs, going forward, context-specific estimates will be important for assessing the economic burden of the disease in these countries as well as useful inputs for assessing the value for money of new COVID-19 vaccines or therapeutic candidates as they become available. Therefore, this webinar will also be forward-looking, discussing ways these estimates can be refined as more data becomes available within LMICs.
Tuesday 8th December at 12pm GMT. The event will be one hour long.
To connect, please use the following information:
Meeting ID: 999 1925 2161